CCND1 and neoplasm: Immunohistochemistry and western blotting analysis of CDX model tumor tissues revealed reduced levels of ENO1, p-AKT, and CCND1 in UCHL3-silenced tumors, while these levels were elevated in tumors overexpressing UCHL3 (Fig. 7G– J).